Abstract
Hypertension is an important public health challenge worldwide. Epigenetic studies are providing novel insight into the underlying mechanisms of hypertension. We investigated the effect of DNA methylation in ATP-binding cassette transporter 1 (ABCA1) gene on blood pressure levels in a Chinese hyperlipidemic population. We randomly selected 211 individuals with hyperlipidemia who had not received any lipid-lowering treatment at baseline from our previous statin pharmacogenetics study (n = 734). DNA methylation loci at the ABCA1 gene were measured by MethylTarget, a next generation bisulfite sequencing-based multiple targeted cytosine-guanine dinucleotide methylation analysis method. Mean DNA methylation level was used in statistical analysis. In all subjects, higher mean ABCA1_B methylation was positively associated with systolic blood pressure (SBP) (β = 8.27, P = 0.008; β = 8.78, P = 0.005) and explained 2.7% and 5.8% of SBP variation before and after adjustment for lipids, respectively. We further divided all patients into three groups based on the tertile of body mass index (BMI) distribution. In the middle tertile of BMI, there was a significantly positive relationship between mean ABCA1_A methylation and SBP (β = 0.89, P = 0.003) and DBP (β = 0.32, P = 0.030). Mean ABCA1_A methylation explained 11.0% of SBP variation and 5.3% of DBP variation, respectively. Furthermore, mean ABCA1_A methylation (β = 0.79; P = 0.007) together with age and gender explained up to 24.1% of SBP variation. Our study provides new evidence that the ABCA1 DNA methylation profile is associated with blood pressure levels, which highlights that DNA methylation might be a significant molecular mechanism involved in the pathophysiological process of hypertension.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365:217–23.
Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–9.
Cowley AW, Nadeau JH, Baccarelli A, Berecek K, Fornage M, Gibbons GH, et al. Report of the National Heart, Lung, and Blood Institute Working Group on epigenetics and hypertension. Hypertension. 2012;59:899–905.
Kotchen TA, AW Cowley, Liang M. Ushering hypertension into a new era of precision medicine. Jama. 2016;315:343–4.
Rodenhiser D, Mann M. Epigenetics and human disease: translating basic biology into clinical applications. CMAJ. 2006;174:341–8.
Frey FJ. Methylation of CpG islands: potential relevance for hypertension and kidney diseases. Nephrol Dial Transpl. 2005;20:868–9.
Wang X, Falkner B, Zhu H, Shi H, Su S, Xu X, et al. A genome-wide methylation study on essential hypertension in young African American males. PLoS One. 2013;8:e53938.
Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet. 2015;47:1282–93.
Wang S, Smith JD. ABCA1 and nascent HDL biogenesis. Biofactors. 2014;40:547–54.
Oram JF. ATP-binding cassette transporter A1 and cholesterol trafficking. Curr Opin Lipido. 2002;13:373–81.
Santamarina-Fojo S, Peterson K, Knapper C, Qiu Y, Freeman L, Cheng JF, et al. Complete genomic sequence of the human ABCA1 gene: analysis of the human and mouse ATP-binding cassette A promoter. Proc Natl Acad Sci USA. 2000;97:7987–92.
Fujii R, Yamada H, Munetsuna E, Yamazaki M, Ando Y, Mizuno G, et al. Associations between dietary vitamin intake, ABCA1 gene promoter DNA methylation, and lipid profles in a Japanese population. Am J Clin Nutr. 2019;110:1213–9.
Hautefort A, Chesné J, Preussner J, Pullamsetti SS, Tost J, Looso M, et al. Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension. Oncotarget. 2017;8:52995–3016.
Zhai YJ, Wu MM, Linck VA, Zou L, Yue Q, Wei SP, et al. Intracellular cholesterol stimulates ENaC by interacting with phosphatidylinositol4,5bisphosphate and mediates cyclosporine A-induced hypertension. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1915–24.
Korkor MT, Meng FB, Xing SY, Zhang MC, Guo JR, Zhu XX, et al. Microarray analysis of differential gene expression profile in peripheral blood cells of patients with human essential hypertension. Int J Med Sci. 2011;8:168–79.
Xu M, Zhou H, Gu Q, Li C. The expression of ATP-binding cassette transporters in hypertensive patients. Hypertens Res. 2009;32:455–61.
Oram JF, Lawn RM. ABCA1. The gatekeeper for eliminating excess tissue cholesterol. J Lipid Res. 2001;42:1173–9.
Ma Y, Follis JL, Smith CE, Tanaka T, Manichaikul AW, Chu AY, et al. Interaction of methylation-related genetic variants with circulating fatty acids on plasma lipids: a meta-analysis of 7 studies and methylation analysis of 3 studies in the Cohorts for Heart and Aging Research in Genomic Epidemiology consortium. Am J Clin Nutr. 2016;103:567–78.
Houde AA, Guay SP, Desgagne V, Hivert MF, Baillargeon JP, St-Pierre J, et al. Adaptations of placental and cord blood ABCA1 DNA methylation profile to maternal metabolic status. Epigenetics. 2013;8:1289–302.
Wang J, Zhang ZR, Chou CF, Liang YY, Gu Y, Ma HP. Cyclosporine stimulates the renal epithelial sodium channel by elevating cholesterol. Am J Physiol Ren Physiol. 2009;296:F284–290.
Pratt JH. Central role for ENaC in development of hypertension. J Am Soc Nephrol. 2005;16:3154–9.
Vogel RA. Cholesterol lowering and endothelial function. Am J Med. 1999;107:479–87.
Agita A, Alsagaff MT. Inflammation, Immunity, and Hypertension. Acta Med Indones. 2017;49:158–65.
Rahmouni K, Correia MLG, Haynes WG, Mark AL. Obesity-associated hypertension: new insights into mechanisms. Hypertension. 2005;45:9–14.
Wang Z, Zeng X, Chen Z, Wang X, Zhang L, Zhu M, et al. Association of visceral and total body fat with hypertension and prehypertension in a middle-aged Chinese population. J Hypertens. 2015;33:1555–62.
Vincent V, Thakkar H, Aggarwal S, Mridha AR, Ramakrishnan L, Singh A. ATP-binding cassette transporter A1 (ABCA1) expression in adipose tissue and its modulation with insulin resistance in obesity. Diabetes Metab Syndr Obes. 2019;12:275–84.
Cuffe H, Liu M, Key CC, Boudyguina E, Sawyer JK, Weckerle A, et al. Targeted Deletion of Adipocyte Abca1 (ATP-Binding Cassette Transporter A1) Impairs Diet-Induced Obesity. Arterioscler Thromb Vasc Biol. 2018;38:733–43.
Ehrlich M. DNA hypermethylation in disease: mechanisms and clinical relevance. Epigenetics. 2019;14:1141–63.
Richardson B. Impact of aging on DNA methylation. Ageing Res Rev. 2003;2:245–61.
Guay SP, Legare C, Houde AA, Mathieu P, Bosse Y, Bouchard L. Acetylsalicylic acid, aging and coronary artery disease are associated with ABCA1 DNA methylation in men. Clin Epigenetics. 2014;6:14.
Talens RP, Christensen K, Putter H, Willemsen G, Christiansen L, Kremer D, et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell. 2012;11:694–703.
Sene A, Khan AA, Cox D, Nakamura RE, Santeford A, Kim BM, et al. Impaired cholesterol efflux in senescent macrophages promotes age-related macular degeneration. Cell Metab. 2013;17:549–61.
Pu W, Wang C, Chen S, Zhao D, Zhou Y, Ma Y, et al. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC). Clin Epigenetics. 2017;9:129.
Ziller MJ, Hansen KD, Meissner A, Aryee MJ. Coverage recommendations for methylation analysis by whole-genome bisulfite sequencing. Nat Methods. 2015;12:230–2.
Acknowledgements
This study was supported by the National Natural Science Foundation of China (No. 81373484, 81141116 and 30700454); Open fund for Discipline Construction, Institute of Physical Science and Information Technology, Anhui University; and the Academic Top Talents Funding of University (No. gxbjZD2016008). We gratefully acknowledge the assistance and cooperation of the faculty and staff of Anhui Medical University and thank all of the participants in our study.
Author information
Authors and Affiliations
Contributions
QC and DZ, literature search, collecting data, processing data, data interpretation, analyzing data, writing manuscript; JF, literature search, data interpretation; SV, data interpretation, commenting on manuscript; SJ & JL, study design, data interpretation, writing manuscript; XX, study design, commenting on manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
All participants provided written informed consent, and the study protocol was approved by the ethics committee of the Institute of Biomedicine, Anhui Medical University. The procedures followed in our study were in accordance with the ethical standards of the Declarations of Helsinki and Istanbul
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Li, Y., Zhang, Q., Di Zhang et al. The effect of ABCA1 gene DNA methylation on blood pressure levels in a Chinese hyperlipidemic population. J Hum Hypertens 35, 1139–1148 (2021). https://doi.org/10.1038/s41371-020-00479-z
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-020-00479-z